Follow the Moberg Pharma AB (publ) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Moberg Pharma AB (publ) has recorded 18 reports. Market capitalisation: €534.1m. The latest transaction was disclosed on 21 August 2026 (Sale). Among the most active insiders: Richard Ding. Every trade is free.
18
Insider Decl.
n/a
Thresholds
€108,690
15 ops.
Buy Volume
€775,781
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Moberg Pharma AB (publ) Strong Buy (bullish), based on 1 analysts. Average price target: SEK 16.00.
41Σ signal
Buys €108,690€775,781 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,490 shares@ SEK 6.4732.4% of flowBTU (betald tecknad unit)ISINISIN SE0015243761FI:A001P100-2
18 of 18 declarations
Acerca de Moberg Pharma AB (publ)
Moberg Pharma AB (publ) es una empresa farmacéutica sueca centrada en el desarrollo de tratamientos para enfermedades de la piel. Cotiza en la Bolsa de Estocolmo (XSTO).